A genomic test being developed by a Charlottesville, Va., company can predict a patient's risk of developing severe COVID-19, new research from UVA Health suggests. That information could help doctors identify patients at ...
Sep 16, 2022
0
145
Barely three months ago, the anti-malarial drug that President Donald Trump touted seemed like such a sure bet against COVID-19 that Susanna Naggie had a tough time setting up a national clinical trial comparing it to placebo. ...
Jul 6, 2020
0
6
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July) shows that covering high-touch (the most regularly touched) surfaces in hospitals ...
Jul 12, 2021
0
21
Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first omicron wave, according to an analysis by researchers at UC San Francisco that examined transmission ...
Jan 2, 2023
0
100
In a recent study, researchers from Karolinska Institutet and others have characterized the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants. The study, published ...
Sep 2, 2022
0
56
Many patients with mild to moderate COVID-19 could become "long haulers," suffering symptoms months after they clear their non-life-threatening infection, new research shows.
Feb 22, 2021
0
72
Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
In a study published this week in the Proceedings of the National Academy of Sciences, virologists from the University of Pittsburgh Center for Vaccine Research reverse-engineered an elusive virus linked to chronic kidney ...
Oct 18, 2022
0
116
A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center. Administration of this vaccine in ...
Jan 25, 2023
0
65
New antiviral pills for COVID-19 recently authorized for emergency use in high-risk people by the U.S. Food and Drug Administration should give doctors an easier means of keeping people out of the hospital.
Dec 29, 2021
0
10
